CPD-002, a novel VEGFR2 inhibitor, relieves rheumatoid arthritis by reducing angiogenesis through the suppression of the VEGFR2/PI3K/AKT signaling pathway
Article in International Immunopharmacology (March 2024)
The most recent citing publications are shown below. View all 100 publications that cite this research output on Dimensions.
Tetramethylpyrazine alleviates hypoxia-induced proliferation, migration, and inflammatory response of fibroblast-like synoviocytes via inhibiting the HIF-1α- circCDC42BPB pathway
Article in Advances in Rheumatology (March 2024)
Hypoxia-induced ALKBH5 aggravates synovial aggression and inflammation in rheumatoid arthritis by regulating the m6A modification of CH25H
Article in Clinical Immunology (February 2024)